Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma.

Elife · 2015 · PMC4478584 · PMID 26047463

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, in some cases, for example, TP53 plus KRAS mutations, there may be a highly significant but still relatively minor deviation from expected rates of co-occurrence.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.